New ALS drug VTx-002 enters first human safety trial
Disease control
Recruiting now
This early-stage study is testing a new experimental drug called VTx-002 in 12 people with ALS. The main goal is to see if the drug is safe and tolerable when given as a single injection into the fluid around the brain and spinal cord. Researchers will also look for signs that th…
Phase: PHASE1, PHASE2 • Sponsor: Vector Y Therapeutics • Aim: Disease control
Last updated May 05, 2026 11:52 UTC